Dr. Elizabeth Ahern, MD
Claim this profileMonash Health
Studies Solid Tumors
Studies Tumors
4 reported clinical trials
8 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
FGFR positive
2Tumors
Stage III
Stage IV
EGFR positive
Clinical Trials Elizabeth Ahern, MD is currently running
CLN-619 + Pembrolizumab
for Cancer
This trial is testing a new drug called CLN-619 alone and with pembrolizumab in patients with advanced solid tumors. These patients may not have other treatment options. Pembrolizumab helps the immune system fight cancer, and they are seeing if CLN-619 can help too.
Recruiting1 award Phase 110 criteria
AU-007
for Advanced Cancer
This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w)
Recruiting1 award Phase 1 & 28 criteria
More about Elizabeth Ahern, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Elizabeth Ahern, MD has experience with
- AU-007
- Aldesleukin
- ICP-192
- Temozolomide
- Radiotherapy
- Surgery
Breakdown of trials Elizabeth Ahern, MD has run
Bladder Cancer
Bile Duct Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth Ahern, MD specialize in?
Elizabeth Ahern, MD focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Elizabeth Ahern, MD currently recruiting for clinical trials?
Yes, Elizabeth Ahern, MD is currently recruiting for 3 clinical trials in Clayton Victoria. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth Ahern, MD has studied deeply?
Yes, Elizabeth Ahern, MD has studied treatments such as AU-007, Aldesleukin, ICP-192.
What is the best way to schedule an appointment with Elizabeth Ahern, MD?
Apply for one of the trials that Elizabeth Ahern, MD is conducting.
What is the office address of Elizabeth Ahern, MD?
The office of Elizabeth Ahern, MD is located at: Monash Health, Clayton, Victoria 3168 Australia. This is the address for their practice at the Monash Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.